Showing results (741-750 of 3,681) with videos related to
Sort By:
Pageof 369
Contemporary Clinical Trials|March 10, 2015
Design of a large outcome trial for a multivalent human papillomavirus L1 virus-like particle vaccineAlain Luxembourg, Oliver Bautista, Erin Moeller, et al.Contemporary Clinical Trials|April 8, 2015
Telephone-adapted mindfulness-based stress reduction (tMBSR) for patients awaiting kidney transplantation: Trial design, rationale and feasibilityMaryanne Reilly-Spong, Diane Reibel, Terry Pearson, et al.Contemporary Clinical Trials|March 18, 2015
Multistage adaptive biomarker-directed targeted design for randomized clinical trialsZhong Gao, Anindya Roy, Ming TanContemporary Clinical Trials|March 14, 2015
Sample size calculations for the design of cluster randomized trials: A summary of methodologyFei Gao, Arul Earnest, David B Matchar, et al.Contemporary Clinical Trials|January 28, 2015
Impact of periodontal disease on outcomes in diabetesKenneth Izuora, Echezona Ezeanolue, Karen Schlauch, et al.Contemporary Clinical Trials|July 6, 2020
A new framework to address challenges in quantitative benefit-risk assessment for medical productsBo Fu, Xuefeng Li, John Scott, et al.Contemporary Clinical Trials|July 8, 2020
Team clinic: Expansion of a multidisciplinary care model for adolescents with type 1 diabetesSarah-Jeanne Salvy, Valerie Ruelas, Shideh Majidi, et al.Contemporary Clinical Trials|August 15, 2012
Examination of a telephone-based exercise intervention for the prevention of postpartum depression: design, methodology, and baseline data from The Healthy Mom studyBeth A Lewis, Dwenda K Gjerdingen, Melissa D Avery, et al.Contemporary Clinical Trials|July 24, 2012
Comparative study on the pregnancy outcomes of in vitro fertilization-embryo transfer between long-acting gonadotropin-releasing hormone agonist combined with transvaginal ultrasound-guided cyst aspiration and long-acting gonadotropin-releasing hormone agonist aloneYi-hong Guo, Na Lu, Yu Zhang, et al.Contemporary Clinical Trials|February 2, 2015
Communication about the risks and benefits of phase I pediatric oncology trialsRebecca A Hazen, Stephen Zyzanski, Justin N Baker, et al.Pageof 369